Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Benefits Of Grapefruit

Two Studies Find Patients Have Lower Health-Related Quality Of Life After Cancer Diagnosis
Cancer patients who are older than 65 years have poorer physical health and, in some cases, mental health when compared with people of the same age group without cancer, according to a study in the June 9 online issue of the Journal of the National Cancer Institute.
generic viagra online
Democratic Female Senators Praise Supreme Court Nominee Sotomayor
Several Democratic female senators on Wednesday took to the floor in a series of speeches praising Supreme Court nominee Sonia Sotomayor and highlighting her judicial qualifications, the Boston Globe"s "Political Intelligence" reports. Sen. Amy Klobuchar (Minn.) -- a member of the Senate Judiciary Committee -- was joined by Sens. Mary Landrieu (La.), Claire McCaskill (Mo.) and Jeanne Shaheen (N.H.).In her address, Klobuchar said that Sotomayor"s experience "particularly resonated with me," adding that Sotomayor "understands the law is not just some dusty book in your basement" and that its interpretation has consequences. McCaskill said that Sotomayor is a nominee with "integrity, grit, intellect and the ability to pass judgment in the most difficult intellectual challenges that face a Supreme Court justice."According to "Political Intelligence," the floor speeches came after Klobuchar and others praised Sotomayor"s nomination at Monday"s annual convention of the left-leaning legal organization the American Constitution Society. In her speech, Klobuchar defended Sotomayor against conservative critics who have questioned the nominee"s temperament, citing complaints that Sotomayor was impatient with unprepared lawyers. Klobuchar said that she is "hoping that we would get to a point in this country where we could be appointing and confirming as many as rough and to-the-point female judges as we have appointed male judges" ("Political Intelligence," Boston Globe, 6/24).
News of the day
Obama Administration Faces Increasing Challenges To Health Reform
The Obama administration is facing increasing opposition to various aspects of health reform proposals - especially the idea of a "public plan."
Endocrinology

Dr. David Fischell To Speak At The EuroPCR Conference In Barcelona On The Detection Of Plaque Rupture With The AngelMed Guardian System.

Angel Medical Systems has announced that Dr. David Fischell, Chief Executive Officer, will be the first featured speaker at the upcoming Out-of-the-box "Session Innovation@EuroPCR09" on May 19 in Barcelona, Spain. EuroPCR is the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Dr. Fischell"s presentation will highlight data from recent human clinical studies showing the AngelMed Guardian System"s ability to detect vulnerable plaque rupture. "When someone has a heart attack, it is typically the result of a blood clot closing one of the three major coronary arteries. When this happens, there is a shift in the ST segment of the heart signal caused by the electrical difference between the portion of the heart muscle fed by the closed artery and the rest of the heart that is still receiving oxygen," says Dr. Fischell. The Guardian System is designed to internally monitor ECG signals in real time, 24-hours-a-day, to detect these ST shifts resulting from coronary occlusions. The System is comprised of an internal implantable device about the size of a pacemaker with a single pacemaker lead into the heart, an external pager-like alerting device, and a programmer that lets physicians read out the heart signals. Early clinical cases have shown the Guardian System"s ability to detect plaque ruptures in patients and warn them to seek immediate medical attention. "Experimental and clinical studies have shown that most of the damage to the heart occurs during the first two hours after coronary occlusion," adds Dr. Fischell. "This device has the potential to warn patients hours--perhaps even days--before a heart attack occurs." The Guardian System is currently available commercially in Brazil, and is in the ALERTS Phase II Pivotal trial in clinical sites across the United States. The first implants in the ALERTS trial took place in December, 2008 with sites across more than 10 states now enrolling patients in the study. Angel Medical is currently ISO 13485 certified and is working with a notified body to gain CE mark approval. Angel Medical Systems


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009